Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 23,612 | 27,461 | 10,161 | 28,650 | 13,288 |
| Cost of Goods | 7,417 | 2,173 | 222 | 2,059 | 1,305 |
| Gross Profit | 16,195 | 25,288 | 9,939 | 26,591 | 11,983 |
| Operating Expenses | 103,615 | 75,065 | 52,726 | 18,921 | 17,897 |
| Operating Income | -87,003 | -49,604 | -42,565 | 7,729 | -5,609 |
| Interest Expense | 7,351 | 1,501 | 335 | 376 | 7,090 |
| Other Income | 4,214 | 5,056 | 16,095 | -15,874 | -95 |
| Pre-tax Income | -90,140 | -46,049 | -26,805 | -8,521 | -12,794 |
| Income Tax | 15,371 | N/A | -33 | 34 | -34 |
| Net Income Continuous | -105,511 | -46,049 | -26,772 | -8,555 | -12,760 |
| Net Income | $-105,511 | $-46,049 | $-26,772 | $-8,555 | $-12,760 |
| EPS Basic Total Ops | -2.28 | -1.30 | -0.78 | -2.11 | -3.21 |
| EPS Basic Continuous Ops | -2.28 | -1.30 | -0.78 | -0.29 | -3.21 |
| EPS Diluted Total Ops | -2.28 | -1.30 | -0.78 | -2.11 | -3.21 |
| EPS Diluted Continuous Ops | -2.28 | -1.30 | -0.78 | -0.29 | -3.21 |
| EPS Diluted Before Non-Recurring Items | -2.28 | -1.30 | -0.69 | -1.23 | -3.00 |
| EBITDA(a) | $-81,504 | $-48,598 | $-41,621 | $8,136 | $-3,031 |